Additional comments on the 2022 Joint ESAIC/ESRA guidelines: regional anaesthesia in patients on antithrombotic drugs
Related Experiment Video
Updated: Jul 7, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Erik Vandermeulen1, Christoph J Schlimp, Sibylle Kietaibl
1From the Department of Anaesthesia, University Hospitals Leuven. Catholic University of Leuven, Leuven, Belgium (EV), the Department of Anaesthesia and Intensive Care Medicine, AUVA Trauma Centre, Linz, Austria (CJS), and the Department of Anaesthesia and Intensive Care, Evangelical Hospital Vienna and Sigmund Freud Private University, Vienna, Austria (SK).
No abstract available in PubMed .
Related Concept Videos
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Rheumatic Heart Disease III: Medical Management
Peripheral Artery Disease III: Interprofessional Care
Venous Thrombosis III: Interprofessional Care

